PMID- 17392498 OWN - NLM STAT- MEDLINE DCOM- 20070925 LR - 20190508 IS - 0006-3363 (Print) IS - 1529-7268 (Electronic) IS - 0006-3363 (Linking) VI - 77 IP - 1 DP - 2007 Jul TI - Epidermal growth factor-like growth factors prevent apoptosis of alcohol-exposed human placental cytotrophoblast cells. PG - 53-60 AB - Maternal alcohol abuse during pregnancy can produce an array of birth defects comprising fetal alcohol syndrome. A hallmark of fetal alcohol syndrome is intrauterine growth retardation, which is associated with elevated apoptosis of placental cytotrophoblast cells. Using a human first trimester cytotrophoblast cell line, we examined the relationship between exposure to ethanol and cytotrophoblast survival, as well as the ameliorating effects of epidermal growth factor (EGF)-like growth factors produced by human cytotrophoblast cells. After exposure to 0-100 mM ethanol, cell death was quantified by the TUNEL method, and expression of the nuclear proliferation marker, Ki67, was measured by immunohistochemistry. The mode of cell death was determined by assessing annexin V binding, caspase 3 activation, pyknotic nuclear morphology, reduction of TUNEL by caspase inhibition, and cellular release of lactate dehydrogenase. Ethanol significantly reduced proliferation and increased cell death approximately 2.5-fold through the apoptotic pathway within 1-2 h of exposure to 50 mM alcohol. Exposure to 25-50 mM ethanol significantly increased transforming growth factor alpha (TGFA) and heparin-binding EGF-like growth factor (HBEGF), but not EGF or amphiregulin (AREG). When cytotrophoblasts were exposed concurrently to 100 mM ethanol and 1 nM HBEGF or TGFA, the increase in apoptosis was prevented, while EGF ameliorated at 10 nM and AREG was weakly effective. HBEGF survival-promoting activity required ligation of either of its cognate receptors, HER1 or HER4. These findings reveal the potential for ethanol to rapidly induce cytotrophoblast apoptosis. However, survival factor induction could provide cytotrophoblasts with an endogenous cytoprotective mechanism. FAU - Wolff, Garen S AU - Wolff GS AD - C.S. Mott Center for Human Growth and Development, Department of Obstetrics & Gynecology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. FAU - Chiang, Po Jen AU - Chiang PJ FAU - Smith, Susan M AU - Smith SM FAU - Romero, Roberto AU - Romero R FAU - Armant, D Randall AU - Armant DR LA - eng GR - R01 AA011085/AA/NIAAA NIH HHS/United States GR - R01 AA011085-10/AA/NIAAA NIH HHS/United States GR - AA12057/AA/NIAAA NIH HHS/United States GR - Intramural NIH HHS/United States GR - AA11085/AA/NIAAA NIH HHS/United States GR - R29 AA011085/AA/NIAAA NIH HHS/United States GR - R37 AA011085/AA/NIAAA NIH HHS/United States GR - R01 AA012057-04/AA/NIAAA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, N.I.H., Intramural PT - Research Support, Non-U.S. Gov't DEP - 20070328 PL - United States TA - Biol Reprod JT - Biology of reproduction JID - 0207224 RN - 0 (Apoptosis Regulatory Proteins) RN - 0 (Caspase Inhibitors) RN - 3K9958V90M (Ethanol) RN - 62229-50-9 (Epidermal Growth Factor) SB - IM MH - Apoptosis/*drug effects MH - Apoptosis Regulatory Proteins/genetics/metabolism MH - Caspase Inhibitors MH - Cell Line MH - Cell Proliferation MH - Dose-Response Relationship, Drug MH - Epidermal Growth Factor/metabolism/*pharmacology MH - Ethanol/*pharmacology MH - Humans MH - Trophoblasts/*cytology/*drug effects/metabolism MH - Up-Regulation PMC - PMC1950777 MID - NIHMS25018 EDAT- 2007/03/30 09:00 MHDA- 2007/09/26 09:00 PMCR- 2007/08/23 CRDT- 2007/03/30 09:00 PHST- 2007/03/30 09:00 [pubmed] PHST- 2007/09/26 09:00 [medline] PHST- 2007/03/30 09:00 [entrez] PHST- 2007/08/23 00:00 [pmc-release] AID - biolreprod.106.057984 [pii] AID - 10.1095/biolreprod.106.057984 [doi] PST - ppublish SO - Biol Reprod. 2007 Jul;77(1):53-60. doi: 10.1095/biolreprod.106.057984. Epub 2007 Mar 28.